TY - JOUR AU - Wydra, Arnika AU - Czajka-Oraniec, Izabella AU - Wydra, Jakub AU - Zgliczynski, Wojciech TI - The influence of growth hormone deficiency on bone health and metabolism JF - REUMATOLOGIA-WARSZAWA J2 - REUMATOLOGIA-WARSZAWA VL - 61 PY - 2023 IS - 4 SP - 239 EP - 247 PG - 9 SN - 0034-6233 DO - 10.5114/reum/170244 UR - https://m2.mtmt.hu/api/publication/34595592 ID - 34595592 AB - Growth hormone (GH) is a key peptide hormone in the regulation of bone metabolism, through its systemic and paracrine action mediated directly as well as by insulin-like growth factor-1 (IGF-1). Growth hormone exerts pleiotropic effects leading to an increase in linear bone growth, accumulation of bone mineral content and preservation of peak bone mass. Furthermore, it influences protein, lipid, and carbohydrate metabolism. Growth hormone deficiency (GHD) causes a low bone turnover rate leading to reduced bone mineral density (BMD) and increased bone fragility. The results of GH insufficiency are the most pronounced among children as it negatively affects longitudinal bone growth, causing short stature and in ado-lescents, in whom it hinders the acquisition of peak bone mass. Most studies show that treatment with recombinant human growth hormone (rhGH) in GHD patients could improve BMD and decrease fracture risk.This review aims to summarize the pathophysiology, clinical picture and management of bone com-plications observed in GHD. LA - English DB - MTMT ER - TY - JOUR AU - Gawne, Richard AU - McKenna, Kenneth Z. AU - Levin, Michael TI - Competitive and Coordinative Interactions between Body Parts Produce Adaptive Developmental Outcomes JF - BIOESSAYS J2 - BIOESSAYS VL - 42 PY - 2020 IS - 8 PG - 11 SN - 0265-9247 DO - 10.1002/bies.201900245 UR - https://m2.mtmt.hu/api/publication/31444995 ID - 31444995 N1 - Allen Discovery Center at Tufts University, Medford, MA 02155, United States Division of Biological Sciences, Section of Cellular and Developmental Biology, University of California San Diego, La Jolla, CA 92093, United States Cited By :10 Export Date: 4 May 2022 CODEN: BIOEE Correspondence Address: Levin, M.; Allen Discovery Center at Tufts UniversityUnited States; email: michael.levin@tufts.edu AB - Large-scale patterns of correlated growth in development are partially driven by competition for metabolic and informational resources. It is argued that competition between organs for limited resources is an important mesoscale morphogenetic mechanism that produces fitness-enhancing correlated growth. At the genetic level, the growth of individual characters appears independent, or "modular," because patterns of expression and transcription are often highly localized, mutations have trait-specific effects, and gene complexes can be co-opted as a unit to produce novel traits. However, body parts are known to interact over the course of ontogeny, and these reciprocal exchanges can be an important determinant of developmental outcomes. Genetic mechanisms underlie cell and tissue behaviors that allow organs to communicate with one another, but they also create evolutionarily adaptive competitive dynamics that are driven by physiological and biophysical processes. Advances in the understanding of competitive and closely related coordinative interactions across scales will complement existing research programs that emphasize the role of cellular mechanisms in morphogenesis. Study of the large-scale order produced by competitive dynamics promises to facilitate advances in basic evolutionary and developmental biology, as well as applied research in fields such as bioengineering and regenerative medicine that aim to regulate patterning outcomes. LA - English DB - MTMT ER - TY - CHAP AU - Lakatos, Péter AU - Bakos, Bence AU - Takács, István AU - Stern, PH ED - Bilezikian, J ED - Martin, TJ ED - Clemens, T ED - Rosen, C TI - Thyroid Hormone and Bone T2 - Principles of Bone Biology PB - Academic Press CY - Cambridge, Massachusetts SN - 9780128148419 PY - 2020 SP - 895 EP - 914 PG - 20 DO - 10.1016/B978-0-12-814841-9.00038-5 UR - https://m2.mtmt.hu/api/publication/30680213 ID - 30680213 N1 - 1st Department of Medicine, Semmelweis University Medical School, Budapest, Hungary Department of Pharmacology, Northwestern University Feinberg, School of Medicine, Chicago, IL, United States Export Date: 6 May 2020 LA - English DB - MTMT ER - TY - JOUR AU - Bakos, Bence AU - Takács, István AU - Stern, P AU - Lakatos, Péter TI - Skeletal Effects of Thyroid Hormones JF - CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM J2 - CLIN REV BONE MINER METABOL VL - 16 PY - 2018 IS - 2 SP - 57 EP - 66 PG - 10 SN - 1534-8644 DO - 10.1007/s12018-018-9246-z UR - https://m2.mtmt.hu/api/publication/3408945 ID - 3408945 N1 - 1st Department of Medicine, Semmelweis University Medical School, Budapest, Hungary Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States Cited By :1 Export Date: 4 May 2022 CODEN: CRBMB Correspondence Address: Bakos, B.; 1st Department of Medicine, Hungary; email: bakos9bence@gmail.com AB - The importance of functional thyroid abnormalities can hardly be overstated as they affect over 5% of the population. Thyroid hormones exert a multitude of effects on the metabolism of both the developing and the adult skeleton. It is thus unsurprising that changes in thyroid function can have a variety of often severe skeletal consequences. In recent years, numerous advances were made in the understanding of this domain. These include for instance the mapping of different pathways mediating genomic and nongenomic actions of thyroid hormones in osteoblasts and osteoclasts, or the investigation of the direct role of thyrotropin in skeletal remodeling. New disease states such as RTH alpha were recently recognized, and the clinical significance of subclinical thyroid dysfunctions in bone pathology is also better understood. In this current paper, we review the influence of thyroid hormones and different forms of thyroid disorders on bone metabolism with a special focus on practical clinical considerations. LA - English DB - MTMT ER - TY - CHAP AU - Frara, S. AU - Maffezzoni, F. AU - Doga, M. AU - Formenti, A.M. AU - Mazziotti, G. AU - Giustina, A. ED - Lenzi, A Migliaccio S TI - GH/IGF-I and bone T2 - Multidisciplinary Approach to Osteoporosis PB - Springer Netherlands CY - Cham SN - 9783319751085 PY - 2018 SP - 83 EP - 106 PG - 24 DO - 10.1007/978-3-319-75110-8_6 UR - https://m2.mtmt.hu/api/publication/30751754 ID - 30751754 N1 - Università Vita-Salute San Raffaele, Milan, Italy ASST Spedali Civili, Brescia, Italy Endocrinology Unit, ASST Carlo Poma, Mantua, Italy Export Date: 29 July 2019 Correspondence Address: Giustina, A.; Università Vita-Salute San RaffaeleItaly Università Vita-Salute San Raffaele, Milan, Italy ASST Spedali Civili, Brescia, Italy Endocrinology Unit, ASST Carlo Poma, Mantua, Italy Export Date: 13 March 2020 Correspondence Address: Giustina, A.; Università Vita-Salute San RaffaeleItaly Università Vita-Salute San Raffaele, Milan, Italy ASST Spedali Civili, Brescia, Italy Endocrinology Unit, ASST Carlo Poma, Mantua, Italy Export Date: 15 March 2020 Correspondence Address: Giustina, A.; Università Vita-Salute San RaffaeleItaly Università Vita-Salute San Raffaele, Milan, Italy ASST Spedali Civili, Brescia, Italy Endocrinology Unit, ASST Carlo Poma, Mantua, Italy Export Date: 1 November 2020 Correspondence Address: Giustina, A.; Università Vita-Salute San RaffaeleItaly Università Vita-Salute San Raffaele, Milan, Italy ASST Spedali Civili, Brescia, Italy Endocrinology Unit, ASST Carlo Poma, Mantua, Italy Export Date: 25 March 2021 Correspondence Address: Giustina, A.; Università Vita-Salute San RaffaeleItaly Università Vita-Salute San Raffaele, Milan, Italy ASST Spedali Civili, Brescia, Italy Endocrinology Unit, ASST Carlo Poma, Mantua, Italy Export Date: 30 March 2021 Correspondence Address: Giustina, A.; Università Vita-Salute San RaffaeleItaly LA - English DB - MTMT ER - TY - JOUR AU - Gilsanz, Vicente AU - Wren, Tishya A L AU - Ponrartana, Skorn AU - Mora, Stefano AU - Rosen, Clifford J TI - Sexual Dimorphism and the Origins of Human Spinal Health JF - ENDOCRINE REVIEWS J2 - ENDOCR REV VL - 39 PY - 2018 IS - 2 SP - 221 EP - 239 PG - 19 SN - 0163-769X DO - 10.1210/er.2017-00147 UR - https://m2.mtmt.hu/api/publication/27548658 ID - 27548658 N1 - Cited By :5 Export Date: 4 May 2022 CODEN: ERVID Correspondence Address: Gilsanz, V.; Children's Hospital Los Angeles, MS #81, 4650 Sunset Boulevard, United States; email: vgilsanz@chla.usc.edu LA - English DB - MTMT ER - TY - JOUR AU - Tritos, Nicholas A TI - Focus on growth hormone deficiency and bone in adults JF - BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM J2 - BEST PRACT RES CL EN VL - 31 PY - 2017 IS - 1 SP - 49 EP - 57 PG - 9 SN - 1521-690X DO - 10.1016/j.beem.2017.02.002 UR - https://m2.mtmt.hu/api/publication/26736359 ID - 26736359 N1 - Összes idézések száma a WoS-ban: 0 Cited By :14 Export Date: 24 May 2021 CODEN: BPRCE Correspondence Address: Tritos, N.A.; Massachusetts General Hospital, Zero Emerson Place # 112, United States; email: ntritos@mgh.harvard.edu Chemicals/CAS: growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; somatomedin C, 67763-96-6; human growth hormone, 12629-01-5; Human Growth Hormone LA - English DB - MTMT ER - TY - JOUR AU - Bassett, J H Duncan AU - Williams, Graham R TI - Role of Thyroid Hormones in Skeletal Development and Bone Maintenance JF - ENDOCRINE REVIEWS J2 - ENDOCR REV VL - 37 PY - 2016 IS - 2 SP - 135 EP - 187 PG - 53 SN - 0163-769X DO - 10.1210/er.2015-1106 UR - https://m2.mtmt.hu/api/publication/25793852 ID - 25793852 N1 - Cited By :221 Export Date: 3 May 2022 CODEN: ERVID Correspondence Address: Williams, G.R.; Molecular Endocrinology Laboratory, 10N5 Commonwealth Building, Hammersmith Campus, United Kingdom; email: graham.williams@imperial.ac.uk Chemicals/CAS: Thyroid Hormones LA - English DB - MTMT ER - TY - JOUR AU - Cheng, Shaohong AU - Xing, Weirong AU - Pourteymoor, Sheila AU - Mohan, Subburaman TI - Effects of Thyroxine (T4), 3,5,3'-triiodo-L-thyronine (T3) and their Metabolites on Osteoblast Differentiation JF - CALCIFIED TISSUE INTERNATIONAL J2 - CALCIFIED TISSUE INT VL - 99 PY - 2016 IS - 4 SP - 435 EP - 442 PG - 8 SN - 0171-967X DO - 10.1007/s00223-016-0159-x UR - https://m2.mtmt.hu/api/publication/26197929 ID - 26197929 N1 - Összes idézések száma a WoS-ban: 0 Musculoskeletal Disease Center, Jerry L Pettis VA Medical Center, 11201 Benton St, Loma Linda, CA 92357, United States Departments of Medicine, Loma Linda University, Loma Linda, CA 92354, United States Cited By :6 Export Date: 13 March 2020 CODEN: CTIND Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Jerry L Pettis VA Medical Center, 11201 Benton St, United States; email: Subburaman.mohan@va.gov Chemicals/CAS: 3,3' diiodothyronine, 70-40-6; 3,3',5' triiodothyronine, 5817-39-0, 70-39-3; liothyronine, 6138-47-2, 6893-02-3; osteocalcin, 136461-80-8; somatomedin C, 67763-96-6; thyroxine, 7488-70-2; thyroxine deiodinase, 70712-46-8; alkaline phosphatase, 9001-78-9; Alkaline Phosphatase; Osteocalcin; Thyroxine; Triiodothyronine Manufacturers: Sigma Aldrich, United States LA - English DB - MTMT ER - TY - JOUR AU - Lindsey, Richard C AU - Mohan, Subburaman TI - Skeletal effects of growth hormone and insulin-like growth factor-I therapy JF - MOLECULAR AND CELLULAR ENDOCRINOLOGY J2 - MOL CELL ENDOCRINOL VL - 432 PY - 2016 IS - C SP - 54 EP - 65 PG - 12 SN - 0303-7207 DO - 10.1016/j.mce.2015.09.017 UR - https://m2.mtmt.hu/api/publication/26197930 ID - 26197930 N1 - Megjegyzés-27654461 N1 Funding details: BLR&D 1-101-BX-001396, VA, U.S. Department of Veterans Affairs N1 Funding details: AR048139, NIH, National Institutes of Health N1 Funding details: 2 R25 GM060507, NIH, National Institutes of Health N1 Funding text: The authors acknowledge funding support from NIH ( AR048139 and 2 R25 GM060507 ) and the US Department of Veterans Affairs ( BLR&D 1-101-BX-001396 ). Musculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, United States Department of Medicine, Loma Linda University, Loma Linda, CA 92354, United States Department of Biochemistry, Loma Linda University, Loma Linda, CA 92354, United States Cited By :20 Export Date: 6 May 2020 CODEN: MCEND Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Loma Linda VA Healthcare System, 11201 Benton Street, United States; email: Subburaman.Mohan@va.gov Chemicals/CAS: growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; somatomedin C, 67763-96-6; Growth Hormone; Insulin-Like Growth Factor I Összes idézések száma a WoS-ban: 0 LA - English DB - MTMT ER - TY - JOUR AU - Lombardi, Giovanni AU - Sanchis-Gomar, Fabian AU - Perego, Silvia AU - Sansoni, Veronica AU - Banfi, Giuseppe TI - Implications of exercise-induced adipo-myokines in bone metabolism JF - ENDOCRINE J2 - ENDOCRINE VL - 54 PY - 2016 IS - 2 SP - 284 EP - 305 PG - 22 SN - 1355-008X DO - 10.1007/s12020-015-0834-0 UR - https://m2.mtmt.hu/api/publication/26373749 ID - 26373749 N1 - Laboratory of Experimental Biochemistry & Molecular Biology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi 4, Milan, 20161, Italy Research Institute Hospital 12 de Octubre (‘i + 12’), Madrid, Spain Vita-Salute San Raffaele University, Milan, Italy Cited By :33 Export Date: 13 March 2020 CODEN: EOCRE Correspondence Address: Lombardi, G.; Laboratory of Experimental Biochemistry & Molecular Biology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi 4, Italy; email: giovanni.lombardi@grupposandonato.it Chemicals/CAS: adiponectin, 283182-39-8; hydrocortisone, 50-23-7; myostatin, 197731-05-8; nicotinamide phosphoribosyltransferase, 9030-27-7; osteocalcin, 136461-80-8; parathyroid hormone, 12584-96-2, 68893-82-3, 9002-64-6; testosterone, 58-22-0; Adipokines LA - English DB - MTMT ER - TY - JOUR AU - Tritos, Nicholas A AU - Klibanski, Anne TI - Effects of Growth Hormone on Bone JF - PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE J2 - PROG MOL BIOL TRANSL SCI VL - 138 PY - 2016 SP - 193 EP - 211 PG - 19 SN - 1877-1173 DO - 10.1016/bs.pmbts.2015.10.008 UR - https://m2.mtmt.hu/api/publication/26040477 ID - 26040477 LA - English DB - MTMT ER - TY - JOUR AU - Tucek, Zvonimir AU - Filipovic, Natalija AU - Masek, Tomislav AU - Stojevic, Zvonko AU - Prvanovic, Nikica AU - Mikulec, Zeljko TI - IGF-I in grazing dairy ewes during late pregnancy and lactation and its correlation to biochemical markers of bone metabolism JF - VETERINARSKI ARHIV J2 - VET ARHIV VL - 84 PY - 2014 IS - 4 SP - 331 EP - 345 PG - 15 SN - 0372-5480 UR - https://m2.mtmt.hu/api/publication/24822025 ID - 24822025 N1 - Összes idézések száma a WoS-ban: 0 Centre for Animal Reproduction of Croatia, Zagreb, Croatia Department of Physiology and Radiobiology, University of Zagreb, Zagreb, Croatia Department of Animal Nutrition and Dietetics, University of Zagreb, Zagreb, Croatia Clinic for Obstetrics and Reproduction, University of Zagreb, Zagreb, Croatia Export Date: 13 March 2020 Correspondence Address: Filipović, N.; Department of Anatomy, Histology and Embryology, Medical School, University of Split, Šoltanska 2, 21000 Split, Croatia; email: nfifilipovic@mefst.hr LA - English DB - MTMT ER - TY - JOUR AU - Kim, Ha-Young AU - Mohan, Subburaman TI - Role and Mechanisms of Actions of Thyroid Hormone on the Skeletal Development JF - BONE RESEARCH J2 - BONE RES VL - 1 PY - 2013 IS - 2 SP - 146 EP - 161 PG - 16 SN - 2095-4700 DO - 10.4248/BR201302004 UR - https://m2.mtmt.hu/api/publication/24822026 ID - 24822026 N1 - Musculoskeletal Disease Center, Loma Linda VA HealthCare System, Loma Linda, CA 92357, United States Departments of Medicine, Loma Linda University, Loma Linda, CA 92354, United States Division of Endocrinology, Department of Internal Medicine, Wonkwang University Sanbon Hospital, Gunpo, South Korea Cited By :30 Export Date: 27 March 2020 Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Loma Linda VA HealthCare SystemUnited States; email: Subburaman.Mohan@va.gov Funding details: National Institutes of Health, NIH, AR048139 Funding text 1: Financial support was received from funding agencies in the United States (NIH grant AR048139 and VA merit review grant). The authors thank Dr. Donna Strong for proof reading the article. Musculoskeletal Disease Center, Loma Linda VA HealthCare System, Loma Linda, CA 92357, United States Departments of Medicine, Loma Linda University, Loma Linda, CA 92354, United States Division of Endocrinology, Department of Internal Medicine, Wonkwang University Sanbon Hospital, Gunpo, South Korea Cited By :39 Export Date: 29 March 2021 Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, United States; email: Subburaman.Mohan@va.gov Funding details: National Institutes of Health, NIH, AR048139 Funding text 1: Financial support was received from funding agencies in the United States (NIH grant AR048139 and VA merit review grant). The authors thank Dr. Donna Strong for proof reading the article. LA - English DB - MTMT ER - TY - CHAP AU - Stern, PH ED - Robert, Marcus ED - David, Feldman ED - David, W. Dempster ED - Marjorie, Luckey ED - Jane, A. Cauley TI - Osteo-Odyssey: A Memoir T2 - Osteoporosis,1-2 PB - Elsevier Inc. CY - Amsterdam SN - 1299668232 PB - Elsevier Inc. PY - 2013 SP - 71 EP - 93 PG - 23 DO - 10.1016/B978-0-12-415853-5.00005-4 UR - https://m2.mtmt.hu/api/publication/24703423 ID - 24703423 N1 - Export Date: 11 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States Export Date: 12 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States Export Date: 13 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States Export Date: 14 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States Export Date: 15 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States Export Date: 6 May 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States Export Date: 22 July 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States LA - English DB - MTMT ER - TY - JOUR AU - Mohan, Subburaman AU - Kesavan, Chandrasekhar TI - Role of Insulin-like Growth Factor-1 in the Regulation of Skeletal Growth JF - CURRENT OSTEOPOROSIS REPORTS J2 - CURR OSTEOPOROS REP VL - 10 PY - 2012 IS - 2 SP - 178 EP - 186 PG - 9 SN - 1544-1873 DO - 10.1007/s11914-012-0100-9 UR - https://m2.mtmt.hu/api/publication/24822027 ID - 24822027 N1 - Cited By :27 Export Date: 12 March 2020 Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Research Service (151), Jerry L Pettis VA Medical Center, 11201 Benton Street, Loma Linda, CA 92357, United States; email: Subburaman.Mohan@va.gov Chemicals/CAS: growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; somatomedin C, 67763-96-6; Insulin-Like Growth Factor I, 67763-96-6 Összes idézések száma a WoS-ban: 0 Cited By :27 Export Date: 13 March 2020 Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Research Service (151), Jerry L Pettis VA Medical Center, 11201 Benton Street, Loma Linda, CA 92357, United States; email: Subburaman.Mohan@va.gov Chemicals/CAS: growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; somatomedin C, 67763-96-6; Insulin-Like Growth Factor I, 67763-96-6 Cited By :28 Export Date: 6 May 2020 Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Research Service (151), Jerry L Pettis VA Medical Center, 11201 Benton Street, Loma Linda, CA 92357, United States; email: Subburaman.Mohan@va.gov Chemicals/CAS: growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; somatomedin C, 67763-96-6; Insulin-Like Growth Factor I, 67763-96-6 LA - English DB - MTMT ER - TY - JOUR AU - Ramajayam, G AU - Vignesh, R C AU - Karthikeyan, S AU - Kumar, K Senthil AU - Karthikeyan, G D AU - Veni, S AU - Sridhar, M AU - Arunakaran, J AU - Aruldhas, M Michael AU - Srinivasan, N TI - Regulation of insulin-like growth factors and their binding proteins by thyroid stimulating hormone in human osteoblast-like (SaOS2) cells JF - MOLECULAR AND CELLULAR BIOCHEMISTRY J2 - MOL CELL BIOCHEM VL - 368 PY - 2012 IS - 1-2 SP - 77 EP - 88 PG - 12 SN - 0300-8177 DO - 10.1007/s11010-012-1345-4 UR - https://m2.mtmt.hu/api/publication/24822028 ID - 24822028 N1 - Összes idézések száma a WoS-ban: 0 Department of Endocrinology, Dr. ALMPGIBMS, University of Madras, Chennai 600 113, India Department of Radiation Oncology, College of Medicine, Chungbuk National University, Cheongju 361-763, South Korea Cited By :9 Export Date: 13 March 2020 CODEN: MCBIB Correspondence Address: Srinivasan, N.; Department of Endocrinology, Dr. ALMPGIBMS, University of Madras, Chennai 600 113, India; email: n_srini2000@yahoo.com Chemicals/CAS: alkaline phosphatase, 9001-78-9; proteinase, 9001-92-7; somatomedin B, 63774-77-6, 67763-97-7; somatomedin C, 67763-96-6; somatomedin binding protein 4, 136653-35-5; somatomedin binding protein 5, 138636-23-4; thyrotropin, 9002-71-5; Alkaline Phosphatase, 3.1.3.1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I, 67763-96-6; Insulin-Like Growth Factor II, 67763-97-7; Pregnancy-Associated Plasma Protein-A, 3.4.24.-; RNA, Messenger; Thyrotropin, 9002-71-5 LA - English DB - MTMT ER - TY - CHAP AU - Stern, Paula H ED - Bronner, Felix ED - Farach-Carson, Mary C ED - Roach, Helmtrud I TI - Thyroid and Thyroid Hormone: Normal Function, Diseases, Disorders, Emerging Therapeutics T2 - Bone-Metabolic Functions and Modulators PB - Springer-Verlag London Ltd CY - London SN - 9781447171560 T3 - Topics in Bone Biology, ISSN 2199-2436 ; 7. PB - Springer-Verlag London Ltd PY - 2012 SP - 69 EP - 86 PG - 18 DO - 10.1007/978-1-4471-2745-1_4 UR - https://m2.mtmt.hu/api/publication/24617177 ID - 24617177 N1 - Cited By :1 Export Date: 12 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., United States; email: p-stern@northwestern.edu Cited By :1 Export Date: 13 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., United States; email: p-stern@northwestern.edu Cited By :1 Export Date: 14 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., United States; email: p-stern@northwestern.edu Cited By :1 Export Date: 15 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., United States; email: p-stern@northwestern.edu Cited By :1 Export Date: 28 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., United States; email: p-stern@northwestern.edu Cited By :1 Export Date: 6 May 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., United States; email: p-stern@northwestern.edu Cited By :1 Export Date: 4 February 2021 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, 303 E. Chicago Ave., United States; email: p-stern@northwestern.edu LA - English DB - MTMT ER - TY - JOUR AU - Li, Guimei AU - Wang, Qian TI - Effects of Recombinant Human Growth Hormone Replacement Therapy on Thyroid Function and Skeletal in Children JF - SHIYONG ERKE LINCHUANG ZAZHI / JOURNAL OF APPLIED CLINICAL PEDIATRICS J2 - SHIYONG ERKE LINCHUANG ZAZHI / J APPL CLIN PEDIATRICS VL - 26 PY - 2011 IS - 20 SP - 1546 EP - 1548 PG - 3 SN - 1003-515X UR - https://m2.mtmt.hu/api/publication/31240334 ID - 31240334 LA - Chinese DB - MTMT ER - TY - JOUR AU - Linares, GR AU - Xing, WR AU - Burghardt, H AU - Baumgartner, B AU - Chen, ST AU - Ricart, W AU - Fernandez-Real, JM AU - Zorzano, A AU - Mohan, S TI - Role of diabetes- and obesity-related protein in the regulation of osteoblast differentiation JF - AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM J2 - AM J PHYSIOL ENDOC M VL - 301 PY - 2011 IS - 1 SP - E40 EP - E48 SN - 0193-1849 DO - 10.1152/ajpendo.00065.2011 UR - https://m2.mtmt.hu/api/publication/22431987 ID - 22431987 N1 - Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda University, Loma Linda, CA, United States Departments of Physiology, Loma Linda University, Loma Linda, CA, United States Departments of Medicine, Loma Linda University, Loma Linda, CA, United States Departments of Biochemistry, Loma Linda University, Loma Linda, CA, United States Departments of Microbiology, Loma Linda University, Loma Linda, CA, United States Departament de Bioquimica I Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Institute for Research in Biomedicine-Barcelona, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas, Barcelona, Spain Section of Diabetes, Endocrinology, and Nutrition, University Hospital of Girona, Biomedical Research Institute 'Dr Josep Trueta', CIBERobn Fisiopatología de la Obesidad y Nutrición, Girona, Spain Cited By :8 Export Date: 12 March 2020 CODEN: AJPMD Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, CA, United States; email: Subburaman.Mohan@va.gov Chemicals/CAS: alkaline phosphatase, 9001-78-9; beta tubulin, 87090-36-6; osteocalcin, 136461-80-8; Nuclear Proteins; Osteocalcin, 104982-03-8; RNA, Small Interfering; TP53INP2 protein, human Összes idézések száma a WoS-ban: 0 Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda University, Loma Linda, CA, United States Departments of Physiology, Loma Linda University, Loma Linda, CA, United States Departments of Medicine, Loma Linda University, Loma Linda, CA, United States Departments of Biochemistry, Loma Linda University, Loma Linda, CA, United States Departments of Microbiology, Loma Linda University, Loma Linda, CA, United States Departament de Bioquimica I Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Institute for Research in Biomedicine-Barcelona, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas, Barcelona, Spain Section of Diabetes, Endocrinology, and Nutrition, University Hospital of Girona, Biomedical Research Institute 'Dr Josep Trueta', CIBERobn Fisiopatología de la Obesidad y Nutrición, Girona, Spain Cited By :8 Export Date: 13 March 2020 CODEN: AJPMD Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, CA, United States; email: Subburaman.Mohan@va.gov Chemicals/CAS: alkaline phosphatase, 9001-78-9; beta tubulin, 87090-36-6; osteocalcin, 136461-80-8; Nuclear Proteins; Osteocalcin, 104982-03-8; RNA, Small Interfering; TP53INP2 protein, human Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda University, Loma Linda, CA, United States Departments of Physiology, Loma Linda University, Loma Linda, CA, United States Departments of Medicine, Loma Linda University, Loma Linda, CA, United States Departments of Biochemistry, Loma Linda University, Loma Linda, CA, United States Departments of Microbiology, Loma Linda University, Loma Linda, CA, United States Departament de Bioquimica I Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Institute for Research in Biomedicine-Barcelona, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas, Barcelona, Spain Section of Diabetes, Endocrinology, and Nutrition, University Hospital of Girona, Biomedical Research Institute 'Dr Josep Trueta', CIBERobn Fisiopatología de la Obesidad y Nutrición, Girona, Spain Cited By :8 Export Date: 6 May 2020 CODEN: AJPMD Correspondence Address: Mohan, S.; Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, CA, United States; email: Subburaman.Mohan@va.gov Chemicals/CAS: alkaline phosphatase, 9001-78-9; beta tubulin, 87090-36-6; osteocalcin, 136461-80-8; Nuclear Proteins; Osteocalcin, 104982-03-8; RNA, Small Interfering; TP53INP2 protein, human LA - English DB - MTMT ER - TY - JOUR AU - Davis, PJ TI - Cytokines and growth factors and thyroid hormone JF - CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY J2 - CURR OPIN ENDOCRINOL DIABETES OBES VL - 15 PY - 2008 IS - 5 SP - 428 EP - 428 PG - 1 SN - 1752-296X DO - 10.1097/MED.0b013e32830eba0e UR - https://m2.mtmt.hu/api/publication/22431989 ID - 22431989 N1 - Összes idézések száma a WoS-ban: 0 Ordway Research Institute, Inc., Albany, NY, United States Ordway Research Institute, Inc., 150 New Scotland Avenue, Albany, NY 12208, United States Cited By :5 Export Date: 13 March 2020 Correspondence Address: Davis, P. J.; Ordway Research Institute, Inc., 150 New Scotland Avenue, Albany, NY 12208, United States; email: pdavis@ordwayresearch.org Chemicals/CAS: epidermal growth factor, 62229-50-9; gamma interferon, 82115-62-6; somatomedin C, 67763-96-6; vasculotropin, 127464-60-2; Cytokines; Intercellular Signaling Peptides and Proteins; Thyroid Hormones LA - English DB - MTMT ER - TY - JOUR AU - Giustina, A AU - Mazziotti, G AU - Canalis, E TI - Growth hormone, insulin-like growth factors, and the skeleton JF - ENDOCRINE REVIEWS J2 - ENDOCR REV VL - 29 PY - 2008 IS - 5 SP - 535 EP - 559 PG - 25 SN - 0163-769X DO - 10.1210/er.2007-0036 UR - https://m2.mtmt.hu/api/publication/22431988 ID - 22431988 N1 - Department of Medical and Surgical Sciences, University of Brescia, 25125 Brescia, Italy Department of Research, Saint Francis Hospital and Medical Center, Hartford, CT 06105, United States University of Connecticut School of Medicine, Farmington, CT 06030, United States Department of Medical and Surgical Sciences, University of Brescia, Montichiari Hospital, Via Ciotti 154, 25018 Montichiari, Italy Cited By :601 Export Date: 29 March 2022 CODEN: ERVID Correspondence Address: Giustina, A.; Department of Medical and Surgical Sciences, Via Ciotti 154, 25018 Montichiari, Italy; email: a.giustina@libero.it Chemicals/CAS: alendronic acid, 66376-36-1; growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; human growth hormone, 12629-01-5; ibutamoren, 159633-92-8, 159634-47-6, 159752-10-0; osteoclast differentiation factor, 200145-93-3; pamidronic acid, 40391-99-9, 57248-88-1; somatomedin binding protein 4, 136653-35-5; somatomedin binding protein 5, 138636-23-4; Growth Hormone, 9002-72-6; Insulin-Like Growth Factor I, 67763-96-6 Tradenames: mk 677 LA - English DB - MTMT ER - TY - CHAP AU - Stern, PH ED - Bilezikian, J P ED - Raisz, L G ED - Martin, T J TI - Thyroid Hormone and Bone T2 - Principles of bone biology VL - 1 PB - Elsevier Academic Press CY - San Diego (CA) CY - Amsterdam SN - 0123738849 PB - Elsevier Inc. PY - 2008 SP - 935 EP - 954 PG - 20 DO - 10.1016/B978-0-12-373884-4.00060-4 UR - https://m2.mtmt.hu/api/publication/27431944 ID - 27431944 N1 - \n Cited By :1 \n Export Date: 12 November 2018 \n Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Il, United States Cited By :1 Export Date: 13 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Il, United States Cited By :1 Export Date: 14 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Il, United States Cited By :1 Export Date: 15 March 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Il, United States Cited By :1 Export Date: 6 May 2020 Correspondence Address: Stern, P.H.; Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Il, United States Összes idézések száma a WoS-ban: 0 LA - English DB - MTMT ER - TY - JOUR AU - Simmons, J AU - Zeitler, P AU - Steelman, J TI - Advances in the Diagnosis and Treatment of Osteoporosis JF - Advances in Pediatrics J2 - Advances in Pediatrics VL - 54 PY - 2007 IS - 1 SP - 85 EP - 114 PG - 30 SN - 0065-3101 DO - 10.1016/j.yapd.2007.03.007 UR - https://m2.mtmt.hu/api/publication/23353668 ID - 23353668 LA - English DB - MTMT ER - TY - JOUR AU - Mikosch, P TI - Effects of thyroid disorders on the bone. Auswirkungen von schilddrüsenfehlfunktionen auf den knochen TS - Auswirkungen von schilddrüsenfehlfunktionen auf den knochen JF - WIENER MEDIZINISCHE WOCHENSCHRIFT J2 - WIEN MED WOCHENSCHR VL - 155 PY - 2005 IS - 19-20 SP - 444 EP - 453 PG - 10 SN - 0043-5341 DO - 10.1007/s10354-005-0222-0 UR - https://m2.mtmt.hu/api/publication/21742729 ID - 21742729 N1 - 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, Klagenfurt, Austria 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, St. Veiterstrasse 47, 9020 Klagenfurt, Austria Cited By :7 Export Date: 13 March 2020 CODEN: WMWOA Correspondence Address: Mikosch, P.; 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, St. Veiterstrasse 47, 9020 Klagenfurt, Austria; email: Peter.Mikosch@lkh-klu.at Chemicals/CAS: levothyroxine, 51-48-9; Antithyroid Agents; Thyroid Hormones; Thyroxine, 7488-70-2 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, Klagenfurt, Austria 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, St. Veiterstrasse 47, 9020 Klagenfurt, Austria Cited By :7 Export Date: 14 March 2020 CODEN: WMWOA Correspondence Address: Mikosch, P.; 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, St. Veiterstrasse 47, 9020 Klagenfurt, Austria; email: Peter.Mikosch@lkh-klu.at Chemicals/CAS: levothyroxine, 51-48-9; Antithyroid Agents; Thyroid Hormones; Thyroxine, 7488-70-2 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, Klagenfurt, Austria 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, St. Veiterstrasse 47, 9020 Klagenfurt, Austria Cited By :7 Export Date: 14 June 2020 CODEN: WMWOA Correspondence Address: Mikosch, P.; 2. Medizinische Abteilung, Landeskrankenhaus Klagenfurt, St. Veiterstrasse 47, 9020 Klagenfurt, Austria; email: Peter.Mikosch@lkh-klu.at Chemicals/CAS: levothyroxine, 51-48-9; Antithyroid Agents; Thyroid Hormones; Thyroxine, 7488-70-2 LA - German DB - MTMT ER - TY - JOUR AU - O'Shea, PJ AU - Bassett, JHD AU - Sriskantharajah, S AU - Ying, H AU - Cheng, SY AU - Williams, GR TI - Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha 1 or beta JF - MOLECULAR ENDOCRINOLOGY J2 - MOL ENDOCRINOL VL - 19 PY - 2005 IS - 12 SP - 3045 EP - 3059 PG - 15 SN - 0888-8809 DO - 10.1210/me.2005-0224 UR - https://m2.mtmt.hu/api/publication/22431990 ID - 22431990 N1 - Összes idézések száma a WoS-ban: 0 Molecular Endocrinology Group, Imperial College London, Hammersmith Campus, London, W12 0NN, United Kingdom Gene Regulation Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, United States Molecular Endocrinology Group, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom Cited By :99 Export Date: 13 March 2020 CODEN: MOENE Correspondence Address: Williams, G.R.; Molecular Endocrinology Group, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom; email: graham.williams@imperial.ac.uk Molecular Sequence Numbers: GENBANK: D00698, L48440, NM_010284, S54008, XM_133508; Chemicals/CAS: Receptor, IGF Type 1, EC 2.7.1.112; Receptors, Somatotropin; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Triiodothyronine, 6893-02-3 LA - English DB - MTMT ER - TY - JOUR AU - Bhattacharyya, RS AU - Stern, PH TI - IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells JF - JOURNAL OF CELLULAR BIOCHEMISTRY J2 - J CELL BIOCHEM VL - 90 PY - 2003 IS - 5 SP - 925 EP - 937 PG - 13 SN - 0730-2312 DO - 10.1002/jcb.10726 UR - https://m2.mtmt.hu/api/publication/22431993 ID - 22431993 N1 - Összes idézések száma a WoS-ban: 0 Cited By :8 Export Date: 13 March 2020 CODEN: JCEBD Correspondence Address: Stern, P.H.; Dept. Molec. Pharmacol./Biol. Chem., 303 E. Chicago Avenue, Chicago, IL 60611, United States; email: p-stern@northwestern.edu Chemicals/CAS: carbon 14, 14762-75-5; mitogen activated protein kinase, 142243-02-5; proline, 147-85-3, 7005-20-1; tritium, 10028-17-8; Culture Media, Conditioned; Enzyme Inhibitors; Insulin-Like Growth Factor I, 67763-96-6; Mitogen-Activated Protein Kinases, EC 2.7.1.37; Proline, 147-85-3; Thymidine, 50-89-5 LA - English DB - MTMT ER - TY - JOUR AU - Lakatos, Péter TI - Pajzsmirigyhormonok és a csont : hasznos vagy káros? JF - ORVOSKÉPZÉS J2 - ORVOSKÉPZÉS VL - 78 PY - 2003 IS - 1 SP - 11 EP - 16 PG - 6 SN - 0030-6037 UR - https://m2.mtmt.hu/api/publication/1807246 ID - 1807246 N1 - I. Belgyógyászati Klinika, Semmelweis Egyetem Általános Orvostudományi Kar, Budapest, Hungary Semmelwesi Egyetem, I. Belgyógyászati Klinika, Korányi Sándor u. 2/A, 1083 Budapest, Hungary Export Date: 6 May 2020 CODEN: ORVOA Correspondence Address: Lakatos, P.; Semmelwesi Egyetem, I. Belgyógyászati Klinika, Korányi Sándor u. 2/A, 1083 Budapest, Hungary LA - Hungarian DB - MTMT ER - TY - JOUR AU - Lakatos, Péter TI - Thyroid hormones: Beneficial or deleterious for bone? JF - CALCIFIED TISSUE INTERNATIONAL J2 - CALCIFIED TISSUE INT VL - 73 PY - 2003 IS - 3 SP - 205 EP - 209 PG - 5 SN - 0171-967X DO - 10.1007/s00223-002-0027-8 UR - https://m2.mtmt.hu/api/publication/1802599 ID - 1802599 N1 - \n Cited By :47 \n Export Date: 12 November 2018 \n CODEN: CTIND \n Correspondence Address: Lakatos, P.; 1st Department of Medicine, Semmelweis University Medical School, Koranyi 2/A, Budapest, H-1083, Hungary; email: lakpet@bell.sote.hu Cited By :51 Export Date: 12 March 2020 CODEN: CTIND Correspondence Address: Lakatos, P.; 1st Department of Medicine, Semmelweis University Medical School, Koranyi 2/A, Budapest, H-1083, Hungary; email: lakpet@bell.sote.hu Chemicals/CAS: thyrotropin, 9002-71-5; Thyroid Hormones Összes idézések száma a WoS-ban: 0 Cited By :51 Export Date: 13 March 2020 CODEN: CTIND Correspondence Address: Lakatos, P.; 1st Department of Medicine, Semmelweis University Medical School, Koranyi 2/A, Budapest, H-1083, Hungary; email: lakpet@bell.sote.hu Chemicals/CAS: thyrotropin, 9002-71-5; Thyroid Hormones Cited By :51 Export Date: 15 March 2020 CODEN: CTIND Correspondence Address: Lakatos, P.; 1st Department of Medicine, Semmelweis University Medical School, Koranyi 2/A, Budapest, H-1083, Hungary; email: lakpet@bell.sote.hu Chemicals/CAS: thyrotropin, 9002-71-5; Thyroid Hormones Cited By :51 Export Date: 6 May 2020 CODEN: CTIND Correspondence Address: Lakatos, P.; 1st Department of Medicine, Semmelweis University Medical School, Koranyi 2/A, Budapest, H-1083, Hungary; email: lakpet@bell.sote.hu Chemicals/CAS: thyrotropin, 9002-71-5; Thyroid Hormones AB - The mechanism of action as well as the clinical effects of thyroid hormones on bone has been of interest for more than a century. With the appearance of new treatment modalities for thyroid function disorders, the accompanying alterations in bone metabolism appeared to be rare. However, the introduction of new diagnostic tools, such as osteodensitometry and biochemical bone markers, has changed our view since they were able to show smaller but important changes in bone mineral metabolism associated with thyroid function disorders. Now, we know that hyperthyroidism is associated with an increased life-time risk for fractures, even after achieving euthyroidism. This fact may play an important role in the higher mortality rate among previously hyperthyroid patients later in life. Subclinical hyperthyroidism may also affect bone density, however, its effect on fracture rate remains to be established. The lack of thyroid hormones will alter normal growth during childhood. Adult hypothyroid patients tend to exhibit higher than normal bone density. Despite rather increased bone quantity, hypothyroidism is accompanied with increased fracture risk before and after diagnosis. The effect of thyroid hormone treatment on bone tissue is somewhat controversial. Nevertheless, only patients with suppressed thyroid-stimulating hormone (TSH) appear to loose bone and have higher fracture incidence, whereas patients with a TSH level in the normal range seem to have similar bone mineral content and fracture rate as euthyroid subjects. In summary, most of thyroid function disorders may result in reduced bone density and/or increased fracture rate that should be taken into consideration at clinical evaluation. LA - English DB - MTMT ER - TY - JOUR AU - Pepene, CE AU - Seck, T AU - Pfeilschifter, J AU - Gozariu, L AU - Ziegler, R AU - Kasperk, CH TI - The effects of triiodothyronine on human osteoblast-like cells metabolism and interactions with growth hormone JF - EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES J2 - EXP CLIN ENDOCR DIAB VL - 111 PY - 2003 IS - 2 SP - 66 EP - 72 PG - 7 SN - 0947-7349 DO - 10.1055/s-2003-39231 UR - https://m2.mtmt.hu/api/publication/22431992 ID - 22431992 N1 - Összes idézések száma a WoS-ban: 0 Department of Internal Medicine I, University of Heidelberg, Heidelberg, Germany Department of Endocrinology, Univ. of Med./Pharmacy Cluj-Napoca, Cluj-Napoca, Romania Clinic of Endocrinology, Louis Pasteur Street 3, 3400 Cluj-Napoca, Romania Cited By :4 Export Date: 13 March 2020 CODEN: ECEDF Correspondence Address: Pepene, C.E.; Clinic of Endocrinology, Louis Pasteur Street 3, 3400 Cluj-Napoca, Romania; email: carmenpepene@yahoo.com Chemicals/CAS: alkaline phosphatase, 9001-78-9; growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; liothyronine, 6138-47-2, 6893-02-3; DNA, 9007-49-2; DNA, Complementary; Human Growth Hormone, 12629-01-5; Procollagen; RNA, Messenger; Thymidine, 50-89-5; Triiodothyronine, 6893-02-3 LA - English DB - MTMT ER - TY - JOUR AU - Harvey, CB AU - O'Shea, PJ AU - Scott, AJ AU - Robson, H AU - Siebler, T AU - Shalet, SM AU - Smarut, J AU - Chassande, O AU - Williams, GR TI - Molecular mechanisms of thyroid hormone effects on bone growth and function JF - MOLECULAR GENETICS AND METABOLISM J2 - MOL GENET METAB VL - 75 PY - 2002 IS - 1 SP - 17 EP - 30 PG - 14 SN - 1096-7192 DO - 10.1006/mgme.2001.3268 UR - https://m2.mtmt.hu/api/publication/22432223 ID - 22432223 N1 - Összes idézések száma a WoS-ban: 5 Division of Medicine and MRC Clinical Sciences Centre, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London, United Kingdom Department of Clinical Research, Christie Hospital NHS Trust, Manchester, United Kingdom Department of Endocrinology, Christie Hospital NHS Trust, Manchester, United Kingdom Laboratoire De Biologie Moléculaire Et Cellulaire De i'Ens De Lyon, UMR 5665 CNRS, LA 913 INRA, Lyon, France Cited By :73 Export Date: 13 March 2020 CODEN: MGMEF Correspondence Address: Williams, G.R.; Molecular Endocrinology Group, MRC Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 ONN, United Kingdom; email: graham.williams@ic.ac.uk Division of Medicine and MRC Clinical Sciences Centre, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London, United Kingdom Department of Clinical Research, Christie Hospital NHS Trust, Manchester, United Kingdom Department of Endocrinology, Christie Hospital NHS Trust, Manchester, United Kingdom Laboratoire De Biologie Moléculaire Et Cellulaire De i'Ens De Lyon, UMR 5665 CNRS, LA 913 INRA, Lyon, France Cited By :73 Export Date: 14 March 2020 CODEN: MGMEF Correspondence Address: Williams, G.R.; Molecular Endocrinology Group, MRC Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 ONN, United Kingdom; email: graham.williams@ic.ac.uk Division of Medicine and MRC Clinical Sciences Centre, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London, United Kingdom Department of Clinical Research, Christie Hospital NHS Trust, Manchester, United Kingdom Department of Endocrinology, Christie Hospital NHS Trust, Manchester, United Kingdom Laboratoire De Biologie Moléculaire Et Cellulaire De i'Ens De Lyon, UMR 5665 CNRS, LA 913 INRA, Lyon, France Cited By :73 Export Date: 15 March 2020 CODEN: MGMEF Correspondence Address: Williams, G.R.; Molecular Endocrinology Group, MRC Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 ONN, United Kingdom; email: graham.williams@ic.ac.uk LA - English DB - MTMT ER - TY - JOUR AU - Robson, H AU - Siebler, T AU - Shalet, S M AU - Williams, G R TI - Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth JF - PEDIATRIC RESEARCH J2 - PEDIATR RES VL - 52 PY - 2002 IS - 2 SP - 137 EP - 147 PG - 11 SN - 0031-3998 DO - 10.1203/01.PDR.0000023494.70201.1C UR - https://m2.mtmt.hu/api/publication/21574047 ID - 21574047 LA - English DB - MTMT ER - TY - JOUR AU - McCarthy, AD AU - Etcheverry, SB AU - Cortizo, AM TI - Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development JF - ACTA DIABETOLOGICA J2 - ACTA DIABETOL VL - 38 PY - 2001 IS - 3 SP - 113 EP - 122 PG - 10 SN - 0940-5429 DO - 10.1007/s005920170007 UR - https://m2.mtmt.hu/api/publication/22431997 ID - 22431997 N1 - Összes idézések száma a WoS-ban: 0 Cited By :66 Export Date: 13 March 2020 CODEN: ACDAE Correspondence Address: Cortizo, A.M.; Dept. of Pathological Biochemistry, Facultad de Cencias Exactas, Universidad Nacional de la Plata, Calle 47 y 115, 1900 La Plata, Argentina Chemicals/CAS: advanced glycation end products-bovine serum albumin; Glycosylation End Products, Advanced; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I, 67763-96-6; Minerals; Serum Albumin, Bovine LA - English DB - MTMT ER - TY - JOUR AU - Pepene, CE AU - Kasperk, CH AU - Pfeilschifter, J AU - Borcsok, I AU - Gozariu, L AU - Ziegler, R AU - Seck, T TI - Effects of triiodothyronine on the insulin-like growth factor system in primary human osteoblastic cells in vitro JF - BONE J2 - BONE VL - 29 PY - 2001 IS - 6 SP - 540 EP - 546 PG - 7 SN - 8756-3282 DO - 10.1016/S8756-3282(01)00607-X UR - https://m2.mtmt.hu/api/publication/22431996 ID - 22431996 N1 - Összes idézések száma a WoS-ban: 0 Department of Internal Medicine i, University of Heidelberg, Heidelberg, Germany Department of Endocrinology, University of Medicine and Pharmacy, Cluj-Napoca, Romania Clinic of Endocrinology, Louis Pasteur Street 3-5, 3400 Cluj-Napoca, Romania Cited By :21 Export Date: 13 March 2020 CODEN: BONED Correspondence Address: Pepene, C.E.; Clinic of Endocrinology, Louis Pasteur Street 3-5, 3400 Cluj-Napoca, Romania; email: carmenpepene@usa.net Chemicals/CAS: liothyronine, 6138-47-2, 6893-02-3; somatomedin B, 63774-77-6, 67763-97-7; somatomedin binding protein 4, 136653-35-5; somatomedin binding protein 5, 138636-23-4; somatomedin C, 67763-96-6 Manufacturers: Sigma Aldrich, Germany LA - English DB - MTMT ER - TY - JOUR AU - Bland, R TI - Steroid hormone receptor expression and action in bone JF - CLINICAL SCIENCE J2 - CLIN SCI VL - 98 PY - 2000 IS - 2 SP - 217 EP - 240 PG - 24 SN - 0143-5221 DO - 10.1042/CS19990252 UR - https://m2.mtmt.hu/api/publication/22431999 ID - 22431999 N1 - Összes idézések száma a WoS-ban: 2 LA - English DB - MTMT ER - TY - JOUR AU - Huang, BK AU - Golden, LA AU - Tarjan, G AU - Madison, LD AU - Stern, PH TI - Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts JF - JOURNAL OF BONE AND MINERAL RESEARCH J2 - J BONE MINER RES VL - 15 PY - 2000 IS - SAN FRANCISCO, CALIFORNIA SP - 188 EP - 197 PG - 10 SN - 0884-0431 DO - 10.1359/jbmr.2000.15.2.188 UR - https://m2.mtmt.hu/api/publication/22432001 ID - 22432001 N1 - Összes idézések száma a WoS-ban: 0 Dept. Molec. Pharmacol./Biol. Chem., NW University Medical School, Chicago, IL, United States Division of Endocrinology, Department of Medicine, NW University Medical School, Chicago, IL, United States Dept. Molec. Pharmacol./Biol. Chem., NW University Medical School, 303 East Chicago Avenue Searle 8-435, Chicago, IL 60611, United States Cited By :56 Export Date: 13 March 2020 CODEN: JBMRE Correspondence Address: Stern, P.H.; Dept. of Molec. Phar./Bio. Chem., Northwestern Univ. Medical School, Searle 8-435, 303 East Chicago Avenue, Chicago, IL 60611, United States Chemicals/CAS: Insulin-Like Growth Factor I, 67763-96-6; Receptors, Thyroid Hormone; Triiodothyronine, 6893-02-3 LA - English DB - MTMT ER - TY - JOUR AU - Hulbert, AJ TI - Thyroid hormones and their effects: a new perspective JF - BIOLOGICAL REVIEWS J2 - BIOL REV VL - 75 PY - 2000 IS - 4 SP - 519 EP - 631 PG - 113 SN - 1464-7931 DO - 10.1111/j.1469-185X.2000.tb00054.x UR - https://m2.mtmt.hu/api/publication/22431998 ID - 22431998 N1 - Összes idézések száma a WoS-ban: 4 Cited By :268 Export Date: 14 March 2020 Correspondence Address: Hulbert, A.J.; Metabolic Research Centre, Department of Biological Sciences, University of Wollongong, Wollongong, NSW, 2522, Australia; email: hulbert@uow.edu.au Chemicals/CAS: 3,3',5' triiodothyronine, 5817-39-0, 70-39-3; diiodothyronine, 1041-01-6; iodothyronine, 29354-16-3; liothyronine, 6138-47-2, 6893-02-3; phenol, 108-95-2, 3229-70-7; thyroxine, 7488-70-2 LA - English DB - MTMT ER - TY - JOUR AU - Lakatos, Péter AU - Földes, János AU - Nagy, Zsolt AU - Takács, István AU - Speer, Gábor AU - Horváth, Csaba AU - Mohan, S AU - Baylink, DJ AU - Stern, PH TI - Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism. JF - THYROID J2 - THYROID VL - 10 PY - 2000 IS - 5 SP - 417 EP - 423 PG - 7 SN - 1050-7256 DO - 10.1089/thy.2000.10.417 UR - https://m2.mtmt.hu/api/publication/1335572 ID - 1335572 AB - The mechanism by which thyroid hormones promote bone growth has not yet been elucidated. In vitro, thyroid hormones stimulate insulin-like growth factor-I (IGF-I) production by osteoblasts, which is important for the anabolic effects of the hormone on bone. To determine whether the IGF-I/IGF binding protein (IGFBP) profile is affected when thyroid hormone production is altered in vivo, we studied 36 women who had recently been diagnosed with hyperthyroidism (age: 29-67 years; 19 with Graves' disease, 17 with toxic nodular goiter) and 36 age-matched healthy women as controls. Serum IGF-I, and its binding proteins (IGFBP-3, IGFBP-4, and IGFBP-5), as well as bone mineral density (BMD) at the lumbar spine, femoral neck, and radius midshaft were measured before and 1 year after antithyroid (methimazole) treatment. Serum IGF-I levels were significantly increased in the hyperthyroid patients before treatment (214 +/- 18.2 ng/mL vs. 145 +/- 21.3 ng/mL; p < 0.05). There was no difference in IGF-I levels of patients with Graves' disease and toxic nodular goiter. Serum IGF-I concentrations returned to normal after treatment with methimazole. Serum IGFBP-3 and IGFBP-4 values were significantly elevated in the hyperthyroid group before treatment (3960 +/- 220 ng/mL and 749.7 +/- 53.1 ng/mL vs. 2701 +/- 180 ng/mL and 489.9 +/- 32.4 ng/mL; p < 0.05 and p < 0.01, respectively) and were reduced to those of controls after treatment. Serum IGFBP-5 of hyperthyroid subjects was not different from that of controls either before or after therapy. Serum free thyroxine showed a positive correlation with serum levels of IGF-I (r = 0.73, p < 0.05), IGFBP-3 (r = 0.59, p < 0.05), and IGFBP-4 (r = 0.67, p < 0.05) but not IGFBP-5. BMD at the radius midshaft was significantly lower in hyperthyroid patients at the start of the study and showed a positive correlation with serum IGF-I (r = 0.58; p < 0.001) and a negative correlation with IGFBP-4 (r = -0.61; p < 0.05). Radius BMD showed a 7.2% increase in the hyperthyroid group after 1 year of methimazole treatment, and the correlation between BMD and serum IGF-I disappeared. Our data indicate that thyroid hormones may influence the IGF-I/IGFBP system in vivo in hyperthyroidism. The anabolic effects of increased levels of IGF-I may be limited in hyperthyroidism due to the increases of inhibitory IGFBPs that can counteract the anabolic effects and contribute to the observed net bone loss. LA - English DB - MTMT ER - TY - JOUR AU - Morales, O AU - Lindgren, U AU - Haldosen, LA TI - Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells JF - JOURNAL OF BONE AND MINERAL RESEARCH J2 - J BONE MINER RES VL - 15 PY - 2000 IS - 11 SP - 2284 EP - 2290 PG - 7 SN - 0884-0431 DO - 10.1359/jbmr.2000.15.11.2284 UR - https://m2.mtmt.hu/api/publication/22432002 ID - 22432002 N1 - Összes idézések száma a WoS-ban: 0 Department of Orthopedic Surgery, Karolinska Institutet, Huddinge Hospital, Huddinge, Sweden Department of Medical Nutrition, Karolinska Institutet Novum, Huddinge, Sweden Cited By :9 Export Date: 13 March 2020 Correspondence Address: Morales, O.; Department of Orthopedic Surgery, Huddinge University Hospital, K54 S-141 86 Huddinge, Sweden Chemicals/CAS: growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; Cell Extracts; DNA, 9007-49-2; DNA-Binding Proteins; Growth Hormone, 9002-72-6; Jak2 protein, rat, 2.7.1.112; Janus Kinase 2, 2.7.1.112; Milk Proteins; Protein-Tyrosine Kinases, 2.7.1.112; Proto-Oncogene Proteins; STAT5 Transcription Factor; Stat5a protein, rat; Stat5b protein, rat; Trans-Activators LA - English DB - MTMT ER - TY - JOUR AU - Pepene, C. AU - Gozariu, L. AU - Duncea, I. AU - Ziegler, R. AU - Kasperk, C. TI - Effects of basic fibroblastic growth factor (bFGF), transforming growth factor beta 1 (TGF-β1) and platelet-derived growth factor-BB (PDGF-BB) on human osteoblastic Sa-Os2 osteosarcoma cells and interactions with triiodothyronine JF - Romanian Journal of Endocrinology J2 - Romanian Journal of Endocrinology VL - 38 PY - 2000 IS - 1-2 SP - 3 EP - 9 PG - 7 SN - 1221-356X UR - https://m2.mtmt.hu/api/publication/31240339 ID - 31240339 N1 - Export Date: 4 May 2022 CODEN: RJENE Correspondence Address: Pepene, C.; Clinic of Endocrinology, , Cluj-Napoca, Romania LA - English DB - MTMT ER - TY - JOUR AU - Seck, T AU - Scheidt-Nave, C AU - Ziegler, R AU - Pfeilschifter, J TI - Positive association between circulating free thyroxine and insulin-like growth factor I concentrations in euthyroid elderly individuals JF - CLINICAL ENDOCRINOLOGY J2 - CLIN ENDOCRINOL VL - 48 PY - 1998 IS - 3 SP - 361 EP - 366 PG - 6 SN - 0300-0664 DO - 10.1046/j.1365-2265.1998.00415.x UR - https://m2.mtmt.hu/api/publication/22432003 ID - 22432003 N1 - Összes idézések száma a WoS-ban: 0 Department of Internal Mediane I, University of Heidelberg, Heidelberg, Germany Department of Internal Medicine I, University of Heidelberg, Luisenstr. 5, D-69115 Heidelberg, Germany Cited By :14 Export Date: 13 March 2020 CODEN: CLENA Correspondence Address: Seck, T.; Department of Internal Medicine, University of Heidelberg, Luisenstr. 5, D 69115 Heidelberg, Germany Chemicals/CAS: Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I, 67763-96-6; Insulin-Like Growth Factor II, 67763-97-7; Thyrotropin, 9002-71-5; Thyroxine, 7488-70-2; Triiodothyronine, 6893-02-3 LA - English DB - MTMT ER - TY - JOUR AU - Földes, János AU - Lakatos, Péter AU - Zsadányi, J AU - Horváth, Csaba TI - Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism JF - EUROPEAN JOURNAL OF ENDOCRINOLOGY J2 - EUR J ENDOCRINOL VL - 136 PY - 1997 IS - 3 SP - 277 EP - 281 PG - 5 SN - 0804-4643 DO - 10.1530/eje.0.1360277 UR - https://m2.mtmt.hu/api/publication/1802563 ID - 1802563 N1 - Összes idézések száma a WoS-ban: 0 Cited By :27 Export Date: 13 March 2020 CODEN: EJOEE Correspondence Address: Foldes, J.; I Department of Medicine, Semmelweis University, Koranyi S. u. 2/a, 1083 Budapest, Hungary Chemicals/CAS: intermedin, 9002-79-3, 9046-72-4; prasterone, 53-43-0 Cited By :28 Export Date: 14 June 2020 CODEN: EJOEE Correspondence Address: Foldes, J.; I Department of Medicine, Semmelweis University, Koranyi S. u. 2/a, 1083 Budapest, Hungary Chemicals/CAS: intermedin, 9002-79-3, 9046-72-4; prasterone, 53-43-0 Cited By :28 Export Date: 13 February 2021 CODEN: EJOEE Correspondence Address: Foldes, J.; I Department of Medicine, Koranyi S. u. 2/a, 1083 Budapest, Hungary Chemicals/CAS: intermedin, 9002-79-3, 9046-72-4; prasterone, 53-43-0 AB - Postmenopausal women with endogenous subclinical hyperthyroidism seem to have reduced bone mass, which does not correlate with serum thyroid hormone levels. Relative insufficiencies of IGF-I and dehydroepiandrosterone sulphate (DHEAS) might be additional risk factors for low bone density in these patients. We measured IGF-I, IGF-binding protein-3 (IGFBP-3) and DHEAS levels together with bone mineral density (BMD) of the femoral neck and lumbar spine in women with an autonomously functioning thyroid nodule. Sixty-three women were classified as subclinical hyperthyroid (31 pre- and 32 postmenopausal) and 39 as overt hyperthyroid (16 pre- and 23 postmenopausal) and results were compared with data obtained from 41 age-matched euthyroid healthy women. In premenopausal women BMD was reduced only in the overt hyperthyroid group, and only in the spine, to 92% (P < 0.05). Serum IGF-I as well as IGFBP-3 were increased in the manifest hyperthyroid group, to 157% (P < 0.001) and 129% (P < 0.05) respectively, whereas DHEAS levels did not change in either premenopausal patient group. In postmenopausal women BMD was significantly reduced both in the subclinical hyperthyroid group (spine to 90% and femoral neck to 88%; P < 0.05), as well as in the hyperthyroid group (spine to 78% and femoral neck to 86%; P < 0.01). In contrast to premenopausal women, serum IGF-I and IGFBP-3 did not change in the two groups who were postmenopausal and serum DHEAS levels were reduced to 58% (P < 0.001) in both postmenopausal groups with subclinical as well as overt hyperthyroidism. In the same two groups of patients, serum IGF-I and DHEAS levels correlated with BMD (femoral neck; both r = 0.50, P < 0.05). In conclusion, women with a solitary autonomous thyroid nodule with subclinical hyperthyroidism have reduced BMD only if they are postmenopausal. This is probably due to the effect of subtle increases in thyroid hormone production together with lack of oestrogen protection of the skeleton. But additional risk factors for the development of enhanced bone loss might be a state of relative IGF-I and DHEAS insufficiency in these patients as well as in postmenopausal women with overt hyperthyroidism. LA - English DB - MTMT ER - TY - JOUR AU - Lakatos, Péter AU - Földes, János AU - Horváth, Csaba AU - Kiss, L AU - Tatrai, A AU - Takács, István AU - Tarjan, G AU - Stern, P H TI - Serum interleukin-6 and bone metabolism in patients with thyroid function disorders JF - JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM J2 - J CLIN ENDOCR METAB VL - 82 PY - 1997 IS - 1 SP - 78 EP - 81 PG - 4 SN - 0021-972X DO - 10.1210/jcem.82.1.3641 UR - https://m2.mtmt.hu/api/publication/1802122 ID - 1802122 N1 - Összes idézések száma a WoS-ban: 0 1st Department of Medicine, Semmelweis University Medical School, Budapest, H-1083, Hungary Hetenyi Geza County Hospital, Szolnok, H-5000, Hungary Dept. Molec. Pharmacol. Biol. Chem., NW University Medical School, Chicago, IL 60611, United States 1st Department of Medicine, Semmelweis University Medical School, Koranyi 2/A, Budapest, H-1083, Hungary Cited By :72 Export Date: 13 March 2020 CODEN: JCEMA Correspondence Address: Lakatos, P.; 1st Department of Medicine, Semmelweis University Medical School, Koranyi 2/A, Budapest H-1083, Hungary Chemicals/CAS: Amino Acids; deoxypyridinoline, 90032-33-0; Interleukin-6; Osteocalcin, 104982-03-8 AB - To determine the possible involvement of interleukin-6(IL-6) in the bone loss of hyperthyroidism, relationships between thyroid status, biochemical and densitometric parameters of bone metabolism, and IL-6 were studied in female subjects. Patients with hyperthyroidism caused by either toxic nodular goiter or Graves' disease had significantly higher serum IL-6 concentrations than normal controls. Within the control group, serum IL-6 was higher in postmenopausal than in premenopausal women, but this influence of menopausal status was not seen in the hyperthyroid patients. The production of IL-6 by blood mononuclear cells was higher in cells from the hyperthyroid women. Bone turnover was increased in the hyperthyroid patients based on serum osteocalcin and urinary deoxypyridinoline excretion, and the hyperthyroid group also had reduced radius bone mineral content (BMC). A subgroup of hyperthyroid patients who had the lowest BMC (values more than 1 SD below normal age-matched controls) also had serum IL-6 concentrations significantly greater than those of hyperthyroid patients showing less reduction of BMC. The correlations observed in this study support the possibility that IL-6 plays a role in mediating the bone loss that results from excess thyroid hormone. LA - English DB - MTMT ER - TY - JOUR AU - VasilatosYounken, R AU - Dunnington, EA AU - Siegel, PB AU - McMurtry, JP TI - Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken JF - GENERAL AND COMPARATIVE ENDOCRINOLOGY J2 - GEN COMP ENDOCR VL - 105 PY - 1997 IS - 1 SP - 31 EP - 39 PG - 9 SN - 0016-6480 DO - 10.1006/gcen.1996.6795 UR - https://m2.mtmt.hu/api/publication/22432004 ID - 22432004 N1 - Összes idézések száma a WoS-ban: 0 Cited By :16 Export Date: 13 March 2020 CODEN: GCENA Correspondence Address: Vasilatos-Younken, R.; Penn State University, 203 William L. Henning Building, University Park, PA 16802-3501, United States; email: rxv@psuvm.psu.edu Chemicals/CAS: growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; liothyronine, 6138-47-2, 6893-02-3; somatomedin C, 67763-96-6; thyroxine, 7488-70-2 LA - English DB - MTMT ER - TY - JOUR AU - Akita, S AU - Hirano, A AU - Fujii, T TI - Identification of IGF-I in the calvarial suture of young rats: Histochemical analysis of the cranial sagittal sutures in a hyperthyroid rat model JF - PLASTIC AND RECONSTRUCTIVE SURGERY J2 - PLAST RECONSTR SURG VL - 97 PY - 1996 IS - 1 SP - 1 EP - 12 PG - 12 SN - 0032-1052 DO - 10.1097/00006534-199601000-00001 UR - https://m2.mtmt.hu/api/publication/22432008 ID - 22432008 N1 - Összes idézések száma a WoS-ban: 0 Cited By :17 Export Date: 13 March 2020 CODEN: PRSUA Correspondence Address: Akita, S.1-7-1 Sakamoto-machi, Nagasaki 852, Japan Chemicals/CAS: Alkaline Phosphatase, EC 3.1.3.1; Biological Markers; Calcium, 7440-70-2; Insulin-Like Growth Factor I, 67763-96-6; Phosphorus, 7723-14-0; Triiodothyronine, 6893-02-3 LA - English DB - MTMT ER - TY - JOUR AU - Glantschnig, H AU - Varga, F AU - Klaushofer, K TI - Thyroid hormone and retinoic acid induce the synthesis of insulin-like growth factor-binding protein-4 in mouse osteoblastic cells JF - ENDOCRINOLOGY J2 - ENDOCRINOLOGY VL - 137 PY - 1996 IS - 1 SP - 281 EP - 286 PG - 6 SN - 0013-7227 DO - 10.1210/en.137.1.281 UR - https://m2.mtmt.hu/api/publication/22432007 ID - 22432007 N1 - Összes idézések száma a WoS-ban: 0 LA - English DB - MTMT ER - TY - JOUR AU - KLAUSHOFER, K AU - VARGA, F AU - GLANTSCHNIG, H AU - FRATZLZELMAN, N AU - CZERWENKA, E AU - LEIS, HJ AU - KOLLER, K AU - PETERLIK, M TI - THE REGULATORY ROLE OF THYROID-HORMONES IN BONE CELL-GROWTH AND DIFFERENTIATION JF - JOURNAL OF NUTRITION J2 - J NUTR VL - 125 PY - 1995 IS - 7S SP - S1996 EP - S2003 SN - 0022-3166 UR - https://m2.mtmt.hu/api/publication/22432227 ID - 22432227 LA - English DB - MTMT ER - TY - JOUR AU - KAWAGUCHI, H AU - PILBEAM, CC AU - RAISZ, LG TI - ANABOLIC EFFECTS OF 3,3',5-TRIIODOTHYRONINE AND TRIIODOTHYROACETIC ACID IN CULTURED NEONATAL MOUSE PARIETAL BONES JF - ENDOCRINOLOGY J2 - ENDOCRINOLOGY VL - 135 PY - 1994 IS - 3 SP - 971 EP - 976 PG - 6 SN - 0013-7227 DO - 10.1210/en.135.3.971 UR - https://m2.mtmt.hu/api/publication/22432011 ID - 22432011 N1 - Összes idézések száma a WoS-ban: 0 LA - English DB - MTMT ER - TY - JOUR AU - VARGA, F AU - RUMPLER, M AU - KLAUSHOFER, K TI - THYROID-HORMONES INCREASE INSULIN-LIKE GROWTH-FACTOR MESSENGER-RNA LEVELS IN THE CLONAL OSTEOBLASTIC CELL-LINE MC3T3-E1 JF - FEBS LETTERS J2 - FEBS LETT VL - 345 PY - 1994 IS - 1 SP - 67 EP - 70 PG - 4 SN - 0014-5793 DO - 10.1016/0014-5793(94)00442-0 UR - https://m2.mtmt.hu/api/publication/22432010 ID - 22432010 N1 - Összes idézések száma a WoS-ban: 0 Cited By :36 Export Date: 13 March 2020 CODEN: FEBLA Correspondence Address: Klaushofer, K.; Ludwig Boltzmann-Institute for Osteology, 4th Medical Department, Hanusch Hospital, Heinrich-Collinstr.30, A-1140 Vienna, Austria Chemicals/CAS: Insulin-Like Growth Factor I, 67763-96-6; RNA, Messenger; Thyroid Hormones; Thyroxine, 7488-70-2; Triiodothyronine, 6893-02-3 Cited By :36 Export Date: 14 March 2020 CODEN: FEBLA Correspondence Address: Klaushofer, K.; Ludwig Boltzmann-Institute for Osteology, 4th Medical Department, Hanusch Hospital, Heinrich-Collinstr.30, A-1140 Vienna, Austria Chemicals/CAS: Insulin-Like Growth Factor I, 67763-96-6; RNA, Messenger; Thyroid Hormones; Thyroxine, 7488-70-2; Triiodothyronine, 6893-02-3 LA - English DB - MTMT ER -